We are live on ! Find out more
CA

Clearstead Advisors Portfolio holdings

AUM $10.9B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+18.41%
3 Year Est. Return
+59.5%
5 Year Est. Return
+69.09%
10 Year Est. Return
AUM
$7.12B
AUM Growth
+$672M
Cap. Flow
+$202M
Cap. Flow %
2.84%
Top 10 Hldgs %
30.81%
Holding
2,906
New
717
Increased
1,154
Reduced
469
Closed
172

Sector Composition

Rank Sector Weight
1 Technology 11.84%
2 Financials 7.35%
3 Industrials 4.85%
4 Consumer Discretionary 3.55%
5 Healthcare 3.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WRLD icon
2576
World Acceptance Corp
WRLD
$950M
$166 ﹤0.01%
+1
New +$143
DIBS icon
2577
1stdibs.com
DIBS
$145M
$160 ﹤0.01%
+58
New +$150
GOOD
2578
Gladstone Commercial Corp
GOOD
$627M
$158 ﹤0.01%
+11
New +$156
BCRX icon
2579
BioCryst Pharmaceuticals
BCRX
$2.37B
$153 ﹤0.01%
+17
New +$158
NSSC icon
2580
Napco Security Technologies
NSSC
$1.28B
$149 ﹤0.01%
+5
New +$129
PLUG icon
2581
Plug Power
PLUG
$2.92B
$149 ﹤0.01%
100
ALTI icon
2582
AlTi Global
ALTI
$378M
$146 ﹤0.01%
+35
New +$121
LZM icon
2583
Lifezone Metals
LZM
$291M
$145 ﹤0.01%
+35
New +$130
BKE icon
2584
Buckle
BKE
$2.19B
$137 ﹤0.01%
+3
New +$119
CBNK icon
2585
Capital Bancorp
CBNK
$588M
$135 ﹤0.01%
+4
New +$123
LAC
2586
Lithium Americas
LAC
$986M
$134 ﹤0.01%
50
CTNM
2587
Contineum Therapeutics
CTNM
$526M
$132 ﹤0.01%
+33
New +$143
ITOS
2588
DELISTED
iTeos Therapeutics
ITOS
$130 ﹤0.01%
+13
New +$105
NKTR icon
2589
Nektar Therapeutics
NKTR
$2.39B
$130 ﹤0.01%
+5
New +$56
BUR icon
2590
Burford Capital
BUR
$907M
$129 ﹤0.01%
+9
New +$118
CBL
2591
CBL Properties
CBL
$1.78B
$127 ﹤0.01%
+5
New +$123
LBRT icon
2592
Liberty Energy
LBRT
$2.83B
$127 ﹤0.01%
+11
New +$133
WLDN icon
2593
Willdan Group
WLDN
$1.1B
$126 ﹤0.01%
+2
New +$95
FBLG icon
2594
FibroBiologics
FBLG
$4.33M
$126 ﹤0.01%
+10
New +$180
LWAY icon
2595
Lifeway Foods
LWAY
$465M
$124 ﹤0.01%
+5
New +$118
STTK icon
2596
Shattuck Labs
STTK
$710M
$123 ﹤0.01%
+155
New +$150
XFOR icon
2597
X4 Pharmaceuticals
XFOR
$363M
$122 ﹤0.01%
+64
New +$262
CURV icon
2598
Torrid Holdings
CURV
$247M
$121 ﹤0.01%
+41
New +$215
SD icon
2599
SandRidge Energy
SD
$510M
$120 ﹤0.01%
+11
New +$112
APLE icon
2600
Apple Hospitality REIT
APLE
$3.96B
$117 ﹤0.01%
+10
New +$117

Similar funds

Clearstead Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Clearstead Advisors held 2,906 positions worth $7.12B, up 10% from $6.45B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Clearstead Advisors's Q2 2025 filing shows 717 new, 1,154 increased, 469 reduced and 172 closed positions. Its largest new stake was Vanguard Intermediate-Term Tax-Exempt Bond ETF: 9,578 shares worth $944K. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $21.3M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.

  • Clearstead Advisors's largest Q2 2025 buy was Vanguard Intermediate-Term Tax-Exempt Bond ETF: 9,578 shares worth $944K.
  • Clearstead Advisors added most to iShares Broad USD High Yield Corporate Bond ETF in Q2 2025, an estimated $22M increase.
  • Clearstead Advisors's biggest Q2 2025 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $21.3M.
  • Clearstead Advisors fully exited Invesco Senior Loan ETF in Q2 2025, selling an estimated $7.86M.
  • Clearstead Advisors's ten largest holdings make up 31% of its $7.12B portfolio in Q2 2025.
  • Clearstead Advisors opened 717 new positions and closed 172 in Q2 2025.
  • Clearstead Advisors's portfolio value rose 10% quarter-over-quarter to $7.12B.

Based on Clearstead Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.